RHT.V
Reliq Health Technologies Inc
Price:  
0.22 
CAD
Volume:  
46,607.00
Canada | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RHT.V WACC - Weighted Average Cost of Capital

The WACC of Reliq Health Technologies Inc (RHT.V) is 6.9%.

The Cost of Equity of Reliq Health Technologies Inc (RHT.V) is 6.95%.
The Cost of Debt of Reliq Health Technologies Inc (RHT.V) is 7.00%.

Range Selected
Cost of equity 5.60% - 8.30% 6.95%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.6% - 8.2% 6.9%
WACC

RHT.V WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.34 0.56
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.60% 8.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.01 0.01
Cost of debt 7.00% 7.00%
After-tax WACC 5.6% 8.2%
Selected WACC 6.9%

RHT.V's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for RHT.V:

cost_of_equity (6.95%) = risk_free_rate (4.15%) + equity_risk_premium (5.60%) * adjusted_beta (0.34) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.